top of page
Photoroom_20250620_150428_edited_edited_

Contract Research Services
Preclinical 3D Cell-Based Assays

Apricell   delivers advanced 3D cell-based assay solutions using organoid and spheroid models powered by the Apricell Proprietary platforms for drug efficacy testing, toxicology, and disease modeling. Powered by our proprietary high-performance culture plates, we offer robust and scalable platforms for academic and pharmaceutical research.

 

As a contract research partner, we specialize in high-throughput assay development, 3D tissue modeling, and quantitative imaging, tailored to meet complex R&D needs. At Apricell, we combine innovation, efficiency, and scientific expertise to accelerate next-generation in vitro testing.

Image-Based Cellular Screening

In image-based cellular screening, high-content imaging (HCI) is used to analyze cell behavior, morphology, and treatment responses. In addition to providing deeper biological insights than traditional assays, this approach also facilitates the discovery of drugs and the testing of toxicity, as well as the development of personalized medicine.

Cell viability assays are essential for measuring the number of healthy, living cells in a population. Cell viability assays are widely used for drug discovery and cancer research to assess how compounds affect cell growth, survival, and therapeutic potential.

Cell Viability/Cytotoxicity Assays

Cell Proliferation Assays

In order to assess cell proliferation, our assays are available in both colorimetric and fluorometric formats. Live cell monitoring allows detection of proliferation kinetics in real-time, while an endpoint assay provides high-throughput methods for assessing the health and growth of cells.

3D Immuno-infiltration

provides a physiologically relevant platform to investigate immune–tumor interactions in vitro. The 3D Immune Cell Infiltration Assay, utilizing proprietary Apricell Platforms, can be employed to evaluate the effects of therapeutic compounds on immune cell infiltration, as well as to screen, profile, and compare immune cell populations for potential use in immunotherapy development and optimization.

bottom of page